Ding Ma

833 citations
19 papers · 471 · 1 hit paper · h-index 9

Impact in

    • RNA modifications and cancer
    • RNA and protein synthesis mechanisms
    • Mitochondrial Function and Pathology
    • RNA Research and Splicing
    • Genomics and Phylogenetic Studies
    • Cancer-related gene regulation
    • Cancer-related molecular mechanisms research

Papers in

    • RNA and protein synthesis mechanisms 5
    • RNA modifications and cancer 4
    • RNA Research and Splicing 3
    • Mitochondrial Function and Pathology 2
    • Genomics and Phylogenetic Studies 2
    • Cervical Cancer and HPV Research 4

Ding Ma

18 papers receiving 457 citations

Ding Ma's Hit Papers

Advances in cervical cancer: current insights and future directions 2024 · 52 citations
520+1Years since publication1020304050

Peers

Ding Ma
Comparison fields: 5 of 57
  • Molecular Biology 367
  • Cancer Research 45
  • Clinical Biochemistry 18
  • Oncology 53
  • Genetics 39
Replace Lars Schomacher with:
Lars Schomacher Germany
F Ye China
Deepa Rajagopalan Singapore
Ting Fu United States
Maria E. Valieva Russia
Samuel Tremblay‐Belzile Canada
Douglas S. Zatechka United States
Jessica J. R. Hudson United Kingdom
David Ding United States
Petria S. Thompson United States
Ding Ma relative to Lars Schomacher Germany Lars Schomacher's profile →
Citations per field
00.5×4.3×
Lars Schomacher · 1×
Citations per year

Countries citing papers authored by Ding Ma

Since Specialization
Citations

This map shows the geographic impact of Ding Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Ma more than expected).

Fields of papers citing papers by Ding Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ding Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Ma. The network helps show where Ding Ma may publish in the future.

Co-authors

The 25 scholars most cited alongside Ding Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ding Ma Line = papers co-authored together Ding Ma links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 2020192
2 198360
3 202154
4
Advances in cervical cancer: current insights and future directions
Hit paper breakdown →
202452
5 202345
6 198820
7 198414
8 202212
9 19868
10 20224
11 20252
12 20252
13 20251
14 20251
15 20251
16 20251
17 20251
18 20241
19 20250

About Ding Ma

Ding Ma is a scholar working on Molecular Biology, Epidemiology, Oncology, Obstetrics and Gynecology and Genetics, having authored 19 papers that have together received 471 indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), Cervical Cancer and HPV Research (4 papers), RNA modifications and cancer (4 papers), RNA Research and Splicing (3 papers), Endometrial and Cervical Cancer Treatments (2 papers), Mitochondrial Function and Pathology (2 papers), Genomics and Phylogenetic Studies (2 papers) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Molecular Biology (367 citations), Cancer Research (45 citations), Clinical Biochemistry (18 citations), Oncology (53 citations) and Genetics (39 citations). Ding Ma has collaborated with scholars based in China, United States and Japan. Frequent co-authors include B.A. Roe, Tsutomu Suzuki, Jong Fu Wong, Xuewei Zhao, Rebecca K. Wilson, Yuriko Sakaguchi, Mari Mito, Shintaro Iwasaki, Takeo Suzuki and Hironori Saito. Their work appears in journals such as Gene, Nature Communications, BMC Medicine, Trends in cancer and Pharmaceuticals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact